RESUMO
Introduction: Patients with the multibacillary form of leprosy can develop reactional episodes of acute inflammation, known as erythema nodosum leprosum (ENL), which are characterized by the appearance of painful cutaneous nodules and systemic symptoms. Neutrophils have been recognized to play a role in the pathogenesis of ENL, and recent global transcriptomic analysis revealed neutrophil-related processes as a signature of ENL skin lesions. Methods: In this study, we expanded this analysis to the blood compartment, comparing whole blood transcriptomics of patients with non-reactional lepromatous leprosy at diagnosis (LL, n=7) and patients with ENL before administration of anti-reactional treatment (ENL, n=15). Furthermore, a follow-up study was performed with patients experiencing an ENL episode at the time of diagnosis and after 7 days of thalidomide treatment (THAL, n=10). Validation in an independent cohort (ENL=8; LL=7) was performed by RT-qPCR. Results: An enrichment of neutrophil activation and degranulation-related genes was observed in the ENL group, with the gene for the neutrophil activation marker CD177 being the most enriched gene of ENL episode when compared to its expression in the LL group. A more pro-inflammatory transcriptome was also observed, with increased expression of genes related to innate immunity. Validation in an independent cohort indicated that S100A8 expression could discriminate ENL from LL. Supernatants of blood cells stimulated in vitro with Mycobacterium leprae sonicate showed higher levels of CD177 compared to the level of untreated cells, indicating that the leprosy bacillus can activate neutrophils expressing CD177. Of note, suggestive higher CD177 protein levels were found in the sera of patients with severe/moderate ENL episodes when compared with patients with mild episodes and LL patients, highlighting CD177 as a potential systemic marker of ENL severity that deserves future confirmation. Furthermore, a follow-up study was performed with patients at the time of ENL diagnosis and after 7 days of thalidomide treatment (THAL, n=10). Enrichment of neutrophil pathways was sustained in the transcriptomic profile of patients undergoing treatment; however, important immune targets that might be relevant to the effect of thalidomide at a systemic level, particularly NLRP6 and IL5RA, were revealed. Discussion: In conclusion, our study reinforces the key role played by neutrophils in ENL pathogenesis and shed lights on potential diagnostic candidates and novel therapeutic targets that could benefit patients with leprosy.
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Hanseníase Virchowiana/imunologia , Hanseníase Virchowiana/sangue , Eritema Nodoso/imunologia , Proteínas Ligadas por GPI , Neutrófilos/imunologiaRESUMO
Hemostatic illnesses are frequently associated with acute and chronic infections. In the present work we demonstrated that leprosy patients developed hemostatic abnormalities, like the formation of an atypical lipid clot mass during sera harvesting, a phenomenon previously observed and never unraveled. We characterize the nature of the "leprosum clot", formed during a protrombotic state developed by some patients. During the proteomic analysis of the leprosum clot we discovered a set of potential serum biomarkers to leprosy reactional episodes diagnosis, which at this moment is based only in clinical features. Taking together, our data suggest that leprosy patients are suffering from a procoagulant status, being beneficiated by the introduction of routine coagulation tests during their treatment, which will aloud physicians to prevent some of the acute clinical symptoms related with superficial vein thrombosis such as cyanosis and tissue necrosis observed during severe cases of leprosy reactional episodes. (AU)
Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Pele/microbiologia , Espectrometria de Massas , Transtornos da Coagulação Sanguínea/microbiologia , Biomarcadores/sangue , Eletroforese em Gel Bidimensional , Hanseníase Virchowiana/complicações , Hanseníase Virchowiana/sangue , Modelos Lineares , Proteômica/métodos , Eletroforese em Gel de Poliacrilamida , Eritema Nodoso/complicações , Eritema Nodoso/sangue , Mycobacterium leprae/isolamento & purificação , Estudos Prospectivos , Estudos RetrospectivosRESUMO
Leprosy is caused by Mycobacterium leprae, which induces chronic granulomatous infection of the skin and peripheral nerves. The disease ranges from the tuberculoid to the lepromatous forms, depending on the cellular immune response of the host. Chemokines are thought to be involved in the immunopathogenesis of leprosy, but few studies have investigated the expression of chemokine receptors on leukocytes of leprosy patients. In the present study, we evaluated 21 leprosy patients (M/F: 16/5) with a new diagnosis from the Dermatology Outpatient Clinic of the University Hospital, Federal University of Minas Gerais. The control group was composed of 20 healthy members (M/F: 15/5) of the community recruited by means of announcements. The expression of CCR2, CCR3, CCR5, and CXCR4 was investigated by flow cytometry on the surface of peripheral blood lymphocytes. There was a decrease in percentage of CD3+CXCR4+ and CD4+CXCR4+ lymphocytes in the peripheral blood of leprosy patients (median [range], 17.6 [2.7-41.9] and 65.3 [3.9-91.9], respectively) compared to the control group (median [range], 43.0 [3.7-61.3] and 77.2 [43.6-93.5], respectively). The percentage of CD4+CXCR4+ was significantly lower in patients with the tuberculoid form (median [range], 45.7 [0.0-83.1]) of the disease, but not in lepromatous patients (median [range], 81.5 [44.9-91.9]). The CXCR4 chemokine receptor may play a role in leprosy immunopathogenesis, probably directing cell migration to tissue lesions in tuberculoid leprosy patients.
Assuntos
Adulto , Feminino , Humanos , Pessoa de Meia-Idade , Adulto Jovem , Hanseníase Virchowiana/sangue , Hanseníase Tuberculoide/sangue , Linfócitos/metabolismo , /metabolismo , Estudos de Casos e Controles , Citometria de Fluxo , Contagem de Linfócitos , Receptores de Quimiocinas/metabolismoRESUMO
INTRODUÇÃO: A talidomida é um fármaco utilizado atualmente no tratamento do eritema nodoso hansênico no Brasil. MÉTODOS: Estudo prospectivo para acompanhar a evolução clínica, registrar os eventos adversos e determinar as concentrações plasmáticas de talidomida em dose diária de 100mg/dia, em 20 pacientes com manifestações clínicas de eritema nodoso hansênico, divididos em dois grupos: após ou em curso da poliquimioterapia para hanseníase. RESULTADOS: Não foram observadas diferenças significativas nos grupos no decorrer do estudo, tanto na evolução clínica favorável dos pacientes, de 70 por cento e 90 por cento, quanto nos eventos adversos registrados que foram tontura e sonolência. Os teores plasmáticos de talidomida em D7 e D14 foram de 0,82±0,4μg/mL e 0,79±0,3μg/mL no grupo 1 e de 0,82±0,4 e 1,55±1,0 no grupo 2, respectivamente. CONCLUSÕES: Na amostra estudada, a poliquimioterapia não interferiu na evolução clínica, na incidência dos efeitos adversos e nos níveis plasmáticos de talidomida.
INTRODUCTION: Thalidomide is a drug currently used in Brazil for treating erythema nodosum leprosum. METHODS: This was a prospective study to follow up clinical evolution, record adverse events and determine plasma thalidomide levels from a dose of 100 mg/day, among 20 patients with clinical manifestations of erythema nodosum leprosum, divided into two groups: during or after leprosy multidrug therapy. RESULTS: No significant differences between the groups were seen during the study, either in relation to favorable clinical evolution among the patients (70 percent and 90 percent), or in relation to the adverse events recorded, which were dizziness and somnolence. The plasma thalidomide levels on D7 and D14 were 0.82 ± 0.4μg/ml and 0.79 ± 0.3 μg/ml in group 1 and 0.82 ± 0.4 and 1.55 ± 1.0 in group 2, respectively. CONCLUSIONS: In this sample, the multidrug therapy had no effect on the clinical evolution, incidence of adverse events and plasma thalidomide levels.
Assuntos
Adolescente , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Eritema Nodoso/tratamento farmacológico , Hansenostáticos/uso terapêutico , Hanseníase Virchowiana/tratamento farmacológico , Talidomida/uso terapêutico , Eritema Nodoso/sangue , Hansenostáticos/efeitos adversos , Hansenostáticos/sangue , Hanseníase Virchowiana/sangue , Estudos Prospectivos , Talidomida/efeitos adversos , Talidomida/sangue , Adulto JovemRESUMO
A hanseníase é uma doneça infecciosa com características únicas, dentre elas o fato de atingir intensamente a inervação da pele e seus anexos. Entremeando estes anexos, está a microcirculação cutânea, que a principio também tem sua inervação comprometida. Vários artigos apontam para alterações de disautonomia microcirculatória, citando como exemplo as alterações no reflexo vasomotor. O presente estudo se propõe a avaliar a microcirculação cutânea na hanseníase virchowiana, tanto em sua morfologia quanto em sua reatividade vascular. Para isto, utilizamos a tecnologia de luz ortogonal polarizada através do equipamento Cytoscan, a análise de Fourier do sinal do laser Doppler para estudo da vasomotricidade e o laser Dopplerfluxometria associado à iontoforese de substâncias vasoativas (acetilcolina, nitroprussiato de sódio e noradrenalina) para avaliação da reatividade vascular. Dez pacientes portadores de hanseníase virchowiana sem outras comorbidades que pudessem alterar os parâmetros microcirculatórios, foram avaliados pelos métodos descritos e seus resultados foram comparados aos de dez controles sem hanseníase ou qualquer outra comorbidade. Em relação à vasomotricidade não foram observadas alterações estatisticamente significativas entre os grupos, o que fala a favor da teoria de origem miogênica para a vasomotricidade. Em relação à iontoforese de substâncias vasoativas constatou-se uma diminuição da resposta vasodilatadora à acetilcolina e ao nitroprussiato nos pacientes com hanseníase. Os exames com o Cytoscan mostraram aumento no tamanho dos capilares, bem como alterações em sua morfologia. Os resultados apresentados sugerem que, provavelmente devido ao longo período de alteração inervatória decorrente da hanseníase virchowiana, estes pacientes apresentam uma alteração significativa tanto morfológica quanto na reatividade vascular da microcirculação cutânea.
Leprosy is an infectious disease with unique characterístics. One of them is the fact that it compromises not only the cutaneous and adnexial innervation, but also the innervation of the cutaneous microcirculation. Several articles indicate the impact of disautonomy on the microcirculatory level, citing the example of changes in vasomotor level. The present study proposes to evaluate morphology and microvascular reactivity of the cutaneous microcirculation of the virchowian leprosy. Methods employed in the study were: the Cytoscan, which uses the orthogonal polarized light, the Fourier analysis of the laser Doppler signal to study vasomotion, and the laser Doppler flowmetry associated with iontophoresis of vasoactive substances (acetylcholine, sodium nitroprusside and norepinephrin). Ten patients with virchowian leprosy, without any other comorbidity that could modify the microvascular parameters were evaluated and their results were compared to ten controls without leprosy or any other comorbidity. Regarding the vasomotion, no statistical significant differences were noticed between the groups. Our data are in agreement with the vasomotion's miogenic origin theory. According to iontophoresis of vasoactive substances, it was found that there is a reduced endothelial-dependent and endothelial-independent vasodilation in patients with leprosy while tests by direct visualization we observed an increase in the size of capillaries, as well as changes in their morphology. The results suggest that the significant changes in morphology and vascular reactivity of skin microcirculation are probably due to the long period of innervatory changes arising from leprosy.
Assuntos
Humanos , Masculino , Feminino , Fluxometria por Laser-Doppler , Hanseníase Virchowiana/sangue , Iontoforese/métodos , Microcirculação/efeitos da radiação , Microcirculação/fisiologia , Microscopia de Polarização/métodos , Microscopia de Polarização , Sistema Nervoso/irrigação sanguínea , Resistência VascularRESUMO
Human phagocyte-specific chitotriosidase is associated with several diseases involving macrophage activation. Since macrophage activation plays an important role in the control of Mycobacterium leprae infection, we studied the association of chitotriosidase with leprosy both in serum and in situ in lesional skin biopsies from patients. Serum samples from 78 Indonesian leprosy patients (39 non-reactional and 39 reactional leprosy patients) and 36 healthy controls (HC) from the same endemic region were investigated. The patients were classified as multibacillary (MB, n=69) or paucibacillary (PB, n=9) based on the bacterial index in slit-skin smears. Thirty-six of the reactional patients had erythema nodosum leprosum (ENL), while only 3 had reversal reaction (RR). Follow-up serum samples after corticosteroid treatment were also obtained from 17 patients with ENL and one with RR. Multibacillary (MB) patients showed increased chitotriosidase activity in serum as compared to paucibacillary (PB) patients and healthy controls. Although no significant difference was observed between reactional and the corresponding non-reactional groups, ENL showed significantly higher chitotriosidase activity as compared to HC. Furthermore, corticosteroid treatment resulted in significant decline of enzyme activity in ENL sera. Chitotriosidase activity correlated with levels of neopterin, another macrophage activation marker, but not with IL-6, IFN-gamma, TNF-alpha and IL-10. Immunohistochemical staining of 6 MB (LL=5, BL=1) lesional skin sections from stored material showed positive staining for chitotriosidase within lipid-laden macrophages suggesting that macrophages are the source of the enzyme detected in serum. Thus, serum chitotriosidase activity is potentially useful in distinguishing MB from PB leprosy and in monitoring response to therapy in ENL.
Assuntos
Humanos , Masculino , Feminino , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Adulto Jovem , Pele/microbiologia , Pele/patologia , Monócitos/microbiologia , Biomarcadores/sangue , Hanseníase Virchowiana/diagnóstico , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/sangue , Células Cultivadas , Citocinas/sangue , Monitoramento de Medicamentos , Corticosteroides/uso terapêutico , Neopterina/sangue , Eritema Nodoso/tratamento farmacológico , Eritema Nodoso/sangue , Hexosaminidases/sangueRESUMO
Neste estudo avaliamos a quantificaçäo do estresse oxidativo no sangue de hasenianos sob efeito ou näo de tratamento específico. Foram coletadas amostras de sangue de 62 portadores de hanseníase e 13 sadios. Destes 62 pacientes, 35 eram de forma multibacilar e faziam tratamento com clofazimina, dapsona e rifampicina; 16 de forma paucibacilar tratados com dapsona e rifampicina; 11 dos pacientes estavam sem tratamento, sendo 5 da forma multibacilar e 6 da forma paucibacilar. As amostras foram levadas para análises laboratoriais onde foram feitas as dosagens de metahemoglobina e contagem de corpos de Heinz. Os resultados encontrados foram submetidos à análise estatística com cálculo da Odds Ratio e Intervalo de Confiança 95 por cento. Concluimos que a doença haseníase näo foi a causadora do estresse oxidativo, e sim a terapêutica administrada, e o grupo que fazia uso da clofazimina apresentou piores resultados, ou seja, maior estresse oxidativo.
Assuntos
Estresse Oxidativo , Hanseníase , Hanseníase Dimorfa , Hanseníase Virchowiana/imunologia , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/sangueRESUMO
A hanseniase e uma doenca infecciosa cronica, cujo curso evolutivo, lento e insidioso, pode ser interrompido por episodios agudos ou subagudos, caracterizando os periodos reacionais. O comprometimento vascular e muito frequente, sendo a vasculite cronica um achado comum no doente multibacilar. Durante os surtos de reacao tipo II foram relatados episodios de tromboses venosa e/ ou arterial, muitas vezes constituindo a causa de obito desses doentes. Analisamos as dosagens plasmaticas de trombomodulina e do antigeno do fator de von Willebrand como marcadores de lesao e disfuncao endotelial, respectivamente, em doentes multibacilares, durante episodios de reacao tipo II e fora dos periodos reacionais. Apos consentimento previo informado, foram coletadas 163 amostras de um total de 34 doentes com hanseniase, formas multibacilares de sofrerem reacao tipo II
Assuntos
Biomarcadores/análise , Endotélio Vascular/lesões , Fator de von Willebrand/análise , Hanseníase Virchowiana/sangue , Trombomodulina/análiseRESUMO
Neste trabalho foram avaliados os parâmetros hematológicos de dezoito pacientes com eritema nodoso hansênico.(ENH). Oito desses pacientes tiveram ENH intenso e moderado e dez pacientes tiveram ENH leve. Os resultados mostraram que os pacientes com ENH intenso e moderado, tiveram alteraçoes significativas nos resultados hematológicos: deficiência de ferro, um tempo aumentado de lise de euglobulina e hiperfibrinogenemia. Contudo, nenhuma alteraçao foi observada nos outros parâmetros estudados (tempo de protrombina, corpos de Heinz e produtos de degradaçao do fibrinogênio) em todos os casos de ENH.